VintaBio

Acquisition, funding and merger involving VintaBio.

• VintaBio has just announced a $64 Million fundraising (posted on April 11 2023).

View the org chart displaying its 6 main executives

Most searched biographies at VintaBio

• David Radspinner, Chief Executive Officer
• Jennifer Kingsley, Chief Commercial Officer
• Shangzhen Zhou, Co-Founder and Chief Technology Officer

Popular executive movements at VintaBio

• Jennifer Kingsley has joined the company as Chief Commercial Officer  (posted on August 17 2023).

Create your alert
to follow the executive moves at VintaBio.

VintaBio has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by VintaBio

• VintaBio Unveils $64M to Back Viral Vector Trailblazers Behind the First Approved Cell and Gene Therapies

Social media about VintaBio

• VintaBio on Wikipedia, Google News & Yahoo Finance
• VintaBio on LinkedIn, Twitter & YouTube

Contact by email its executives including David Radspinner

Call VintaBio at +1 215...

View the org chart

Register to receive your alert

Report an error